Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Jiangsu Hengrui Medicine

July 2026

  • Home
  • Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine Market Share Analysis for July 2026

恒瑞医药是一家从事创新和高品质药品研制及推广的民族制药企业,已发展成为国内知名的抗肿瘤药、手术用药和影像介入产品的供应商。2020年,公司入选全球投行torreya公布的全球1000强药企榜单,位列第21位。在美国制药经理人杂志(pharmexec)公布的2021年全球制药企业top50榜单中,恒瑞医药排名连续三年攀升,位列第38位
Year Founded1970
Employees> 10001
Annual Revenue--
hengrui.com
Jiangsu Hengrui Medicine
Jiangsu Hengrui Medicine (including company regionals)
  • hengrui.com
    hengrui.com
See more website traffic and engagement information

Jiangsu Hengrui Medicine Stock price in July 2026

Jiangsu Hengrui Medicine stock is traded under the ticker #1276. Below you can review Jiangsu Hengrui Medicine stock performance in the past 12 months up to July 2026


Total visits to Jiangsu Hengrui Medicine's top domains

Understand Jiangsu Hengrui Medicine market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Jiangsu Hengrui Medicine's top domains

Analyze Jiangsu Hengrui Medicine engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Jiangsu Hengrui Medicine's top domains

See how Jiangsu Hengrui Medicine keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Jiangsu Hengrui Medicine

These are the website technologies, by industry, used by Jiangsu Hengrui Medicine top domains

Mobile (3)

Meta Viewport

Meta Viewport

Advertising (2)

PubMatic

PubMatic

Conversion & Analytics (1)

Baidu Analytics

Baidu Analytics

eCommerce (1)

Vtex Enterprise

Vtex Enterprise

More Technologies

3

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Jiangsu Hengrui Medicine

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHengrui attended event American Society of Clinical Oncology Annual Meeting on Jul 1st '26.Hengrui participated in the American Society of Clinical Oncology Annual Meeting for the 16th consecutive year, with 91 studies accepted, including 11 oral presentations - a new high for the Company.
NewsHengrui had earnings of $326M on Jun 1st '26.For the most recent quarter through June, Hengrui achieved a net profit of 2.2 billion yuan ($326.5 million), a Reuters calculation showed, compared with an average analyst forecast of 2.9 billion yuan, according to LSEG data.
NewsHengrui had revenue of $2.29B on Apr 1st '26.In the first half of 2026, Hengrui reported revenue of RMB15.46 billion.

See all Jiangsu Hengrui Medicine signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.